SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001415889-14-001314
Filing Date
2014-05-01
Accepted
2014-05-01 16:31:40
Documents
5
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 ecte10kadec312013.htm 10-K/A 80879
2 LICENSE DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BY AND BETWEEN THE COMPANY A ex10-31.htm EX-10.31 391003
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14 (A) UNDER THE S ex31-1.htm EX-31.1 3994
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14 (A) UNDER THE S ex31-2.htm EX-31.2 4013
5 ecte10kadec3120130.jpg GRAPHIC 18942
  Complete submission text file 0001415889-14-001314.txt   507490
Mailing Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103
Business Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103 215-717-4100
Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)

IRS No.: 411649949 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35218 | Film No.: 14805457
SIC: 3845 Electromedical & Electrotherapeutic Apparatus